Overview
What the Diagnosis Means
Male hypogonadism is a clinical syndrome, not a laboratory label.
CNPLE
CNPLE
Male hypogonadism is a clinical syndrome, not a laboratory label. The diagnosis requires compatible signs or symptoms together with consistently low serum testosterone. A single low result may reflect timing, acute illness, assay variation, or altered sex hormone-binding globulin (SHBG); symptoms alone may arise from depression, sleep deprivation, obesity, medication effects, chronic disease, or relationship and sexual-health concerns. The hypothalamus releases gonadotropin-releasing hormone, which stimulates pituitary luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates testicular Leydig cells to produce testosterone. FSH, together with intratesticular testosterone, supports Sertoli-cell function and sperm production. Testosterone therefore affects sexual function, erythropoiesis, muscle and bone health, energy, and mood, while the same gonadal axis is also central to fertility. The physiological pattern helps locate the failure: - Primary hypogonadism originates in the testes. Testosterone is low, while LH and FSH rise because the pituitary is trying to stimulate an underperforming gonad. - Secondary or central hypogonadism originates in the hypothalamus or pituitary. Testosterone is low, but LH and FSH are low or inappropriately normal; they are not responding adequately to the low testosterone signal....
Unlock full lesson + practice questions
7 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this CNPLE pathway. You can still explore topic-filtered questions from the bank hubs below.